Lead Advisor, New Marketplace

Leemore Dafny, PhD

MBA Class of 1960 Professor of Business Administration
Harvard Business School


Leemore Dafny is the MBA Class of 1960 Professor of Business Administration at the Harvard Business School. Prior to joining the Harvard faculty in 2016, she served as Director of Health Enterprise Management and Professor of Strategy at the Kellogg School of Management at Northwestern University. Her research examines competitive interactions among payers and providers of healthcare services, and the intersection of industry and public policy. Dafny’s work has been published in academic journals such as the American Economic Review and The New England Journal of Medicine, and featured in popular media such as The New York Times and The Wall Street Journal.

Current projects include studies of consolidation in the U.S. hospital industry and the kidney dialysis industry, products and pricing on the public health insurance exchanges, copayment coupons for prescription drugs, and the implications of for-profit ownership of insurance companies.

Dafny graduated summa cum laude from Harvard College and worked as a consultant with McKinsey & Company prior to earning her PhD in economics from the Massachusetts Institute of Technology. She has won several teaching awards as well as Kellogg’s leading research prize, the Stanley Reiter Best Paper award. Dafny is a Research Associate of the National Bureau of Economic Research, Editor of The International Journal of Health Economics and Management, and a Board Member of the American Society of Health Economists and the Health Care Cost Institute.

Dafny’s expertise spans both the public and private sectors. She currently serves on the Panel of Health Advisers for the Congressional Budget Office. In 2012–2013, she was Deputy Director for Healthcare and Antitrust in the Bureau of Economics at the Federal Trade Commission in Washington, DC. Dafny advises companies, government agencies, and nonprofits on a variety of issues including antitrust matters, strategic decisions, and public policy.

New Marketplace
New Risk, New Business Models

New Marketplace Survey: The Sources of Health Care Innovation

Start-ups from outside health care are the most likely source of much-needed innovation, say NEJM Catalyst Insights Council members.

Leemore Dafny Profit Cycle Talk Still: Rules of Business = Rules of Health Care

New Marketplace
New Risk, New Business Models

Rules of Business = Rules of Health Care

The same rules of business apply for health care when it comes to new market opportunity.

New Marketplace
New Risk, New Business Models

Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry

Although it’s not yet clear how providers will respond to value-based payment models, an examination of pharmaceutical industry practices can provide insights into problems that may arise — and practices to avoid.

Fernandopulle, Dafny & Kosowsky Panel Clip Still: New Health Care Entrants: Friends or Foes?

New Marketplace
New Risk, New Business Models

New Entrants: Friends or Foes?

New entrants to health care typically don’t see themselves as competitors to incumbents — but the incumbents do.

Kosowsky03 Panel Clip Still: How Can Health Care Innovators Stay Ahead of Imitation?

New Marketplace
New Risk, New Business Models

Innovation vs. Imitation: Staying Ahead of the Game

When a newbie comes in that hasn’t had to fight the fight, how do you get your customers to stay with you?

Panel Clip Still: Overcoming New Entrants' Big Barriers

New Marketplace
New Risk, New Business Models

Overcoming the Fear of Doing Something Different

How two new health care entrants overcame their biggest barriers to success.

Rushika Fernandopulle Panel Clip Still: Sculpting the Pieta of Health Care

New Marketplace
New Risk, New Business Models

Sculpting the Pieta of Health Care

When you start from scratch, that’s how you achieve good care.

New Marketplace
New Risk, New Business Models

New Health Care Risks Present Opportunities

For decades, health care was among the least risky business sectors. No longer. Today, any health care organization seeking a sustainable market position must focus on serving the customer — the patient.

New Marketplace
New Risk, New Business Models

The Risks of Health Insurance Company Mergers

Consolidations don’t always deliver on their potential.

New Marketplace
New Risk, New Business Models

Myth: Antitrust Enforcers Block Many Hospital Mergers

Authorities place “guardrails” on the merger highway, but they don’t set the speed or direction.

Load More
Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now